Bloom Diagnostics announced the introduction of the new Bloom Inflammation Test, which measures C-reactive protein (CRP) in the blood to detect inflammation in the body.
QIAGEN NV launched QIAstat Dx Rise and innovative panels. The QIA stat-Dx Rise and its test cartridges provide a self-contained system for easy sample preparation and processing.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 1379
Published Date: Oct 11, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The growing prevalence of cancer and growing demand for personalized medicines are some of the major factors anticipated to drive the growth of the cellular health screening market.
The market is anticipated to attain a CAGR of ~10% over the forecast period, i.e., 2024-2036.
The major players in the market are of Quest Diagnostics, Bio-Reference Laboratories Inc., QIAGEN NV, Bloom Diagnostics, Cell Science System Corporation, Laboratory Corporation of American Holdings, and others.
The hospital segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.